Company intelligence / Profile preview

JMWORKS

Geumchun-gu, Seoul, South Koreajmworks.com ↗

Ownership: Private
Employees: ~51
Development stage: Other

Overview

The company has established itself as a leader in medical aesthetic devices and cosmeceuticals with global distribution in over 38 countries. Its flagship TurtlePin® micro-multi-needle injection device is widely used by professionals for direct drug delivery with minimal pain or side effects.

Therapeutic areas: Dermatology
Modalities: Medical deviceCosmeceutical productNutraceutical supplement
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on JMWORKS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JMWORKS.

Explore the full profile